KARO PHARMA INVEST AS

Signals

1 flags

• ▼ Driftsunderskudd 2025 Siste driftsresultat er negativt (−8k kr).

KARO PHARMA INVEST AS is registered as a limited company in Arendal, Agder with organisation number 924548711. The business is classified under uoppgitt (NACE 00.000). The company was incorporated in 2020. Registered share capital is NOK 30,000, divided into 30000 shares. The company's stated purpose is: “Eie aksjer samt investering og forvaltning av aksjer.”. The most recent filed accounts, for the 2025 financial year, show NOK 0 in revenue and NOK −8,000 in operating profit.

Key figures · 2025

Revenue

NOK 0

Operating profit

NOK −8,000

Equity

NOK 740,000

Est. value

NOK 2.0m

Financial health · 2025

Liquidity

–

Not available

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

99.9%

Very good

Equity as a share of total capital

Who owns KARO PHARMA INVEST AS?

RABIH KAROUNI

100.0%

KARO PHARMA INVEST AS

NOK 0 rev. · NOK −8,000 profit

KARO PHARMA INVEST AS has 1 registered shareholder:

• RABIH KAROUNI 100.0%

All shareholders and roles →

Which companies does KARO PHARMA INVEST AS own?

KARO PHARMA INVEST AS holds stakes in 2 companies:

• STOA APOTEK AS 25.0%
• NEDENES APOTEK AS 24.5%

See the full ownership structure →

Frequently asked questions about KARO PHARMA INVEST AS

Who owns KARO PHARMA INVEST AS?

RABIH KAROUNI is the largest registered owner, with 100.0%.

What is the revenue of KARO PHARMA INVEST AS?

KARO PHARMA INVEST AS had revenue of NOK 0 in 2025.

Who is the general manager of KARO PHARMA INVEST AS?

Rabih Karouni is registered as general manager of KARO PHARMA INVEST AS.

Where is KARO PHARMA INVEST AS based?

KARO PHARMA INVEST AS has its business address in Arendal.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.